Signature patterns of human papillomavirus type 16 in invasive anal carcinoma

Human Pathology

Volumn 44, Issue 6, 2013, Pages 992-1002

  Valmary Degano, Séverine ^a,b,c   Jacquin, Elise ^a,b   Prétet, Jean Luc ^a,b,c,d   Monnien, Franck ^c   Girardo, Benoit ^c   Arbez Gindre, Francine ^c   Joly, Marie ^c   Bosset, Jean François ^a,b,c   Kantelip, Bernadette ^a,b,c   Mougin, Christiane ^a,b,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b IFR133 ^*  (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d INSERM   (France)

Author keywords

Anal carcinoma; HPV genotype; Integration; p16; Viral load

Indexed keywords

ALBUMIN; PROTEIN P53; TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; EPISOME; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84878110183     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.08.019     Document Type: Article

References (42)

1. D.M. Parkin The global health burden of infection-associated cancers in the year 2002 Int J Cancer 118 2006 3030 3044
2. L. Abramowitz, V. Remy, and A. Vainchtock Economic burden of anal cancer management in France Rev Epidemiol Sante Publique 58 2010 331 338
3. G.R. Williams, and I.C. Talbot Anal carcinoma - a histological review Histopathology 25 1994 507 516
4. J.R. Daling, M.M. Madeleine, and L.G. Johnson Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 2004 270 280
5. A.D. Varnai, M. Bollmann, and H. Griefingholt HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis Int J Colorectal Dis 21 2006 135 142
6. H. De Vuyst, G.M. Clifford, M.C. Nascimento, M.M. Madeleine, and S. Franceschi Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 2009 1626 1636
7. J.M. Palefsky, and M. Rubin The epidemiology of anal human papillomavirus and related neoplasia Obstet Gynecol Clin North Am 36 2009 187 200
8. L. Abramowitz, A.C. Jacquard, and F. Jaroud Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study Int J Cancer 129 2011 433 439
9. W. Scheurlen, A. Stremlau, L. Gissmann, D. Hohn, H.P. Zenner, and H. zur Hausen Rearranged HPV 16 molecules in an anal and in a laryngeal carcinoma Int J Cancer 38 1986 671 676
10. J.H. Scholefield, J.G. Palmer, N.A. Shepherd, S. Love, K.J. Miller, and J.M. Northover Clinical and pathological correlates of HPV type 16 DNA in anal cancer Int J Colorectal Dis 5 1990 219 222
11. I.E. Salit, J. Tinmouth, and S. Chong Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology Cancer Epidemiol Biomarkers Prev 18 2009 1986 1992
12. H.Y. Yhim, N.R. Lee, and E.K. Song The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy Int J Cancer 129 2011 1752 1760
13. J.A. Ajani, X. Wang, and J.G. Izzo Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation Dig Dis Sci 55 2010 1098 1105
14. S.R. Bonin, T.F. Pajak, and A.H. Russell Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04 Radiation Therapy Oncology Group Cancer 85 1999 1226 1233
15. D.W. Lu, S.K. El-Mofty, and H.L. Wang Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA Mod Pathol 16 2003 692 699
16. H. zur Hausen Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1288 1996 F55 F78
17. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
18. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
19. M.E. McLaughlin-Drubin, and K. Munger Oncogenic activities of human papillomaviruses Virus Res 143 2009 195 208
20. T. Yugawa, and T. Kiyono Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins Rev Med Virol 19 2009 97 113
21. J.L. Pretet, A.C. Jacquard, and X. Carcopino Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study Int J Cancer 122 2008 424 427
22. M. Saunier, S. Monnier-Benoit, and F. Mauny Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma J Clin Microbiol 46 2008 3678 3685
23. D. Taylor, W.M. Koch, M. Zahurak, K. Shah, D. Sidransky, and W.H. Westra Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations Hum Pathol 30 1999 1221 1225
24. B.E. Hoots, J.M. Palefsky, J.M. Pimenta, and J.S. Smith Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions Int J Cancer 124 2009 2375 2383
25. M. Frisch, B. Glimelius, and A.J. van den Brule Sexually transmitted infection as a cause of anal cancer N Engl J Med 337 1997 1350 1358
26. A.K. Wong, R.C. Chan, N. Aggarwal, M.K. Singh, W.S. Nichols, and S. Bose Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies Mod Pathol 23 2010 144 150
27. W. Theelen, E.J. Speel, and M. Herfs Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay Am J Pathol 177 2010 2022 2033
28. S. Monnier-Benoit, V. Dalstein, D. Riethmuller, N. Lalaoui, C. Mougin, and J.L. Pretet Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions J Clin Virol 35 2006 270 277
29. M.P. Canadas, L. Darwich, and G. Sirera Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men Sex Transm Dis 37 2010 311 315
30. P. Peitsaro, B. Johansson, and S. Syrjanen Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique J Clin Microbiol 40 2002 886 891
31. A.H. Hopman, F. Smedts, and W. Dignef Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities J Pathol 202 2004 23 33
32. R. Klaes, T. Friedrich, and D. Spitkovsky Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 2001 276 284
33. M. Branca, C. Giorgi, and D. Santini Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer Am J Clin Pathol 124 2005 113 121
34. A.E. Walts, J. Lechago, and S. Bose P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia Am J Surg Pathol 30 2006 795 801
35. J.R. Gage, C. Meyers, and F.O. Wettstein The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties J Virol 64 1990 723 730
36. M. Indinnimeo, C. Cicchini, and A. Stazi Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma J Exp Clin Cancer Res 19 2000 471 475
37. P.J. Snijders, R.D. Steenbergen, B. Top, S.D. Scott, C.J. Meijer, and J.M. Walboomers Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus J Gen Virol 75 Pt 10 1994 2769 2775
38. T. Crook, and K.H. Vousden Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens EMBO J 11 1992 3935 3940
39. R. Santopietro, I. Shabalova, and N. Petrovichev Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union Cancer Epidemiol Biomarkers Prev 15 2006 1250 1256
40. P. Michieli, M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, and D. Givol Induction of WAF1/CIP1 by a p53-independent pathway Cancer Res 54 1994 3391 3395
41. K. Milde-Langosch, S. Riethdorf, A. Kraus-Poppinghaus, L. Riethdorf, and T. Loning Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas Virchows Arch 439 2001 55 61
42. H. Hiyama, A. Iavarone, and S.A. Reeves Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F Oncogene 16 1998 1513 1523